메뉴 건너뛰기




Volumn 130, Issue 9, 2010, Pages 1058-1064

Moxifloxacin in the treatment of acute bacterial rhinosinusitis: Results of a multicenter, non-interventional study

Author keywords

Effectiveness; Safety; Tolerability

Indexed keywords

MOXIFLOXACIN;

EID: 77956039709     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016481003629036     Document Type: Article
Times cited : (4)

References (7)
  • 1
    • 33344461525 scopus 로고    scopus 로고
    • Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-2002
    • Schappert SM, Burt CW. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-2002. Vital Health Stat 2006;13:1-66.
    • (2006) Vital Health Stat , vol.13 , pp. 1-66
    • Schappert, S.M.1    Burt, C.W.2
  • 2
    • 3543087841 scopus 로고    scopus 로고
    • Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis
    • Anon JB, Jacobs MR, Poole MD, Ambrose PG, Benninger MS, Hadley JA, et al. Sinus And Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004;130 (Suppl 1):1-45.
    • (2004) Otolaryngol Head Neck Surg , vol.130 , Issue.SUPPL. 1 , pp. 1-45
    • Anon, J.B.1    Jacobs, M.R.2    Poole, M.D.3    Ambrose, P.G.4    Benninger, M.S.5    Hadley, J.A.6
  • 3
    • 0043156138 scopus 로고    scopus 로고
    • The Alexander Project 1998- 2000: Susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents
    • Alexander Project Group
    • Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN; Alexander Project Group. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003;52:229-246
    • (2003) J Antimicrob Chemother , vol.52 , pp. 229-246
    • Jacobs, M.R.1    Felmingham, D.2    Appelbaum, P.C.3    Grüneberg, R.N.4
  • 4
    • 33746025939 scopus 로고    scopus 로고
    • Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis
    • Ariza H, Rojas R, Johnson P, Gower R, Benson A, Herrington J, et al. Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis. BMC Ear Nose Throat Disord 2006;6:8.
    • (2006) BMC Ear Nose Throat Disord , vol.6 , pp. 8
    • Ariza, H.1    Rojas, R.2    Johnson, P.3    Gower, R.4    Benson, A.5    Herrington, J.6
  • 6
    • 1542511331 scopus 로고    scopus 로고
    • Efficacy and tolerability of moxifloxacin in the treatment of acute bacterial sinusitis caused by penicillin-resistant Streptococcus pneumoniae: A pooled analysis
    • Johnson P, Cihon C, Herrington J, Choudhri S. Efficacy and tolerability of moxifloxacin in the treatment of acute bacterial sinusitis caused by penicillin-resistant Streptococcus pneumoniae: a pooled analysis. Clin Ther 2004;26:224-231
    • (2004) Clin Ther , vol.26 , pp. 224-231
    • Johnson, P.1    Cihon, C.2    Herrington, J.3    Choudhri, S.4
  • 7
    • 33645751070 scopus 로고    scopus 로고
    • Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: A retrospective database analysis of treatment duration, outcomes, and charges
    • Keating KN, Friedman HS, Perfetto EM. Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges. Curr Med Res Opin 2006;22:327-333
    • (2006) Curr Med Res Opin , vol.22 , pp. 327-333
    • Keating, K.N.1    Friedman, H.S.2    Perfetto, E.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.